Evidence map›Paper›PMID 25347074›Full record

ArticlePloS one2014

New insights into the structure and mode of action of Mo-CBP3, an antifungal chitin-binding protein of Moringa oleifera seeds.

Adelina B Batista, José T A Oliveira, Juliana M Gifoni, Mirella L Pereira, Marina G G Almeida, Valdirene M Gomes, Maura Da Cunha, Suzanna F F Ribeiro, Germana B Dias, Leila M Beltramini and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 50 citations in OpenAlex.

  1. Advancing the Understanding of the Mo-CBPProbiotics and antimicrobial proteins · 2026
    Article
  2. Life (Basel, Switzerland) · 2025
    Review
  3. Review
  4. Proximate Analysis ofInternational journal of molecular sciences · 2023
    Article
  5. Leucine-Rich, Potent Anti-Bacterial Protein againstMolecules (Basel, Switzerland) · 2022
    Article
  6. Article
  7. The Latex Protein MLX56 from Mulberry (Frontiers in plant science · 2017
    Article
  8. A Chitin-binding Protein Purified fromFrontiers in microbiology · 2017
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Adelina B BatistaDepartment of Biochemistry and Molecular Biology, Federal University of Ceará, Fortaleza, Ceará, Brazil.
José T A OliveiraDepartment of Biochemistry and Molecular Biology, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Juliana M GifoniDepartment of Biochemistry and Molecular Biology, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Mirella L PereiraDepartment of Biochemistry and Molecular Biology, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Marina G G AlmeidaDepartment of Biochemistry and Molecular Biology, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Valdirene M GomesBioscience and Biotecnology Center, State University of North Fluminense, Campos dos Goytacazes, Rio de Janeiro, Brazil.
Maura Da CunhaBioscience and Biotecnology Center, State University of North Fluminense, Campos dos Goytacazes, Rio de Janeiro, Brazil.
Suzanna F F RibeiroBioscience and Biotecnology Center, State University of North Fluminense, Campos dos Goytacazes, Rio de Janeiro, Brazil.
Germana B DiasBioscience and Biotecnology Center, State University of North Fluminense, Campos dos Goytacazes, Rio de Janeiro, Brazil.
Leila M BeltraminiPhysics Institute of São Carlos, University of São Paulo, São Carlos, São Paulo, Brazil.
José Luiz S LopesPhysics Institute of São Carlos, University of São Paulo, São Carlos, São Paulo, Brazil.
Thalles B GrangeiroDepartment of Biology, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Ilka M VasconcelosDepartment of Biochemistry and Molecular Biology, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Universidade Federal do Ceará · BRState University of Norte Fluminense · BRUniversidade de São Paulo · BRUniversidade Federal de São Carlos · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mo-CBP3 is a chitin-binding protein purified from Moringa oleifera Lam. seeds that displays inhibitory activity against phytopathogenic fungi. This study investigated the structural properties and the antifungal mode of action of this protein. To this end, circular dichroism spectroscopy, antifungal assays, measurements of the production of reactive oxygen species and microscopic analyses were utilized. Mo-CBP3 is composed of 30.3% α-helices, 16.3% β-sheets, 22.3% turns and 30.4% unordered forms. The Mo-CBP3 structure is highly stable and retains its antifungal activity regardless of temperature and pH. Fusarium solani was used as a model organism for studying the mechanisms by which this protein acts as an antifungal agent. Mo-CBP3 significantly inhibited spore germination and mycelial growth at 0.05 mg.mL-1. Mo-CBP3 has both fungistatic and fungicidal effects, depending on the concentration used. Binding of Mo-CBP3 to the fungal cell surface is achieved, at least in part, via electrostatic interactions, as salt was able to reduce its inhibitory effect. Mo-CBP3 induced the production of ROS and caused disorganization of both the cytoplasm and the plasma membrane in F. solani cells. Based on its high stability and specific toxicity, with broad-spectrum efficacy against important phytopathogenic fungi at low inhibitory concentrations but not to human cells, Mo-CBP3 has great potential for the development of new antifungal drugs or transgenic crops with enhanced resistance to phytopathogens.

Indexed as

Antifungal AgentsChitinColletotrichumFusariumMoringa oleiferaPlant ProteinsProtein BindingProtein StabilitySeedsSpores, FungalAntifungal AgentsChitinPlant Proteins

Identifiers

PMID25347074
PMCPMC4210214
OpenAlexW1980362046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.